| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $69,325,526 ) (Continued on the next page) |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | K23AI187708 | Active and passive humoral immunity to enteric adenovirus infection in Bangladeshi children | 000 | 2 | NIH | 3/2/2026 | $192,212 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI183581 | Biophysical and functional coupling of protein condensates to ordered lipid domains in T-cells | 000 | 2 | NIH | 12/10/2025 | $663,178 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI189455 | Host lipid acquisition and maintenance of the Chlamydia replicative niche | 000 | 1 | NIH | 2/9/2026 | $717,952 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA279681 | Function of the METTL3-NUP93 complex-mediated nuclear export of m6A-modified mRNAs in castration-resistant prostate cancer. | 000 | 3 | NIH | 1/7/2026 | $382,418 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM152065 | Rapid Synthesis of Topologically Complex Molecules with Tungsten Dearomatization Agents | 000 | 3 | NIH | 1/8/2026 | $343,690 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AG080773 | Mevalonate Pathway Regulation of Astrocyte ApoE | 000 | 4 | NIH | 12/15/2025 | $411,774 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AG086344 | Alzheimer's Disease Therapy via the MR Image-Guided Deletion of Microglial SHIP-1 with Focused Ultrasound | 000 | 2 | NIH | 3/3/2026 | $760,384 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI158596 | Understanding A Molecular Cascade That Drives Neutrophil Mediated Pathology In Arthritis | 000 | 4 | NIH | 1/29/2026 | $489,918 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI176515 | Globally Appropriate Genome Reduced Killed Whole Bacterial HIV Vaccines | 000 | 4 | NIH | 3/2/2026 | $282,625 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA282436 | weSipSmarter: An efficacy trial to reduce sugary beverages among rural Head Start parent-child dyads | 000 | 3 | NIH | 3/3/2026 | $669,251 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DK132786 | Mechanisms of ER-Protein Quality Control in Podocytes | 000 | 4 | NIH | 12/19/2025 | $402,984 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL176892 | G6PD Deficiency and Atherosclerosis | 000 | 2 | NIH | 2/16/2026 | $323,000 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01NS126265 | Novel immunotherapeutic potential of DGKalpha inhibition for glioblastoma | 001 | 4 | NIH | 3/5/2026 | $39,900 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DK141617 | Impact of obesity on microvascular insulin action and cardiorespiratory fitness in Type 1 Diabetes | 000 | 1 | NIH | 2/17/2026 | $782,459 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R21AG092022 | 3-hydroxybutyrate: an unexpected longevity factor in yeast | 000 | 2 | NIH | 12/3/2025 | $196,543 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DK051562 | Improving intensive insulin therapy through the personalization of data-driven decision support system to patients’ goals and preferences and its adaptation to long term health needs | 000 | 24 | NIH | 2/19/2026 | $804,338 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DK128077 | Novel role of endoplasmic reticulum-associated degradation in iron metabolism | 000 | 5 | NIH | 12/4/2025 | $403,750 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI179778 | Host factors in shigellosis | 000 | 3 | NIH | 11/24/2025 | $702,315 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL168041 | Targeted treatment of acute lung injury using isolated lung perfusion | 000 | 3 | NIH | 2/12/2026 | $765,632 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL168405 | Epigenetic targeting and nanoplatform-enabled local drug delivery - a two-pronged approach to stenosis prevention after vascular surgery | 000 | 3 | NIH | 2/16/2026 | $676,770 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM162212 | Mechanisms of Genome Integrity Maintenance: Break-Induced Replication at Repetitive DNA Sequences | 000 | 1 | NIH | 2/19/2026 | $444,125 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM152130 | ARFs, ORPs and the control of cell migration | 000 | 3 | NIH | 12/11/2025 | $363,375 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA256199 | A premalignant chronology of cell-state variability in basal-like breast cancer | 000 | 5 | NIH | 12/11/2025 | $589,939 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA259573 | Role of UTX condensation in chromatin regulation | 000 | 5 | NIH | 12/17/2025 | $303,581 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA269594 | Targeting AVIL, a novel oncogene in rhabdomyosarcoma | 000 | 4 | NIH | 12/18/2025 | $453,284 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA288612 | Targeting tumor-specific epitope for imaging and therapy for mesothelioma | 000 | 2 | NIH | 12/17/2025 | $612,666 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R21DC021023 | Development of an MRI Guided Machine Learning Algorithm to Assess the Velopharyngeal Mechanism | 001 | 3 | NIH | 2/10/2026 | $20,187 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI137080 | Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults | 001 | 9 | NIH | 2/12/2026 | $146,449 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R21CA297427 | Elucidate the role of B/T cell-enriched immune aggregates in immune surveillance against TNBC | 000 | 2 | NIH | 12/5/2025 | $169,879 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM144130 | Synthesis, secretion and assembly of extracellular complex carbohydrates in Gram-negative bacteria | 000 | 5 | NIH | 12/16/2025 | $473,161 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | F31DK139601 | The reninness score: integrative analysis of multi-omic data to define renin cell identity | 000 | 2 | NIH | 12/9/2025 | $40,760 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL168405 | Epigenetic targeting and nanoplatform-enabled local drug delivery - a two-pronged approach to stenosis prevention after vascular surgery | 002 | 3 | NIH | 3/16/2026 | $21,371 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01NS126265 | Novel immunotherapeutic potential of DGKalpha inhibition for glioblastoma | 000 | 4 | NIH | 12/10/2025 | $359,097 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35HL184172 | Visualizing Sodium in Lymphatic Disease: a Translational Path | 000 | 1 | NIH | 3/16/2026 | $950,550 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R21DC021023 | Development of an MRI Guided Machine Learning Algorithm to Assess the Velopharyngeal Mechanism | 000 | 3 | NIH | 12/11/2025 | $181,688 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA279134 | MR Image-Guided Drug Delivery to Cerebral Cavernous Malformations with Focused Ultrasound | 000 | 3 | NIH | 12/16/2025 | $553,784 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | F30HD111307 | Localized mitochondrial metabolic activity in Xenopus mesendoderm cells undergoing collective cell migration | 000 | 3 | NIH | 12/5/2025 | $54,538 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01MH140184 | Synchronous network activity in the maturing prefrontal cortex: mechanistic impact of birth timing and serotonin | 000 | 2 | NIH | 2/9/2026 | $392,982 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R37CA269776 | Optimizing psychosocial intervention for breast cancer-related sexual morbidity: A factorial trial using the National Cancer Institute Community Oncology Research Program (NCORP) network | 000 | 4 | NIH | 12/11/2025 | $531,855 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL162783 | Molecular understanding of the GSDMB-regulated innate immune response | 000 | 4 | NIH | 2/9/2026 | $560,004 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA259054 | The Role of ZEB1 in promoting therapeutic resistance through its interaction with 53BP1 | 000 | 5 | NIH | 2/9/2026 | $332,488 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DK145849 | Development of a ketone-aware automated insulin delivery system to enable safe use of sodium-glucose cotransporter inhibitors in people with type 1 diabetes | 000 | 1 | NIH | 1/31/2026 | $788,831 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DA052893 | An investigation of low-intensity focused ultrasound for addiction | 001 | 5 | NIH | 2/6/2026 | $56,631 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | F31MH136730 | Using computational modeling to formalize an integrated psychosocial theory of loneliness | 000 | 2 | NIH | 2/5/2026 | $27,164 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM161604 | How the structural complexity of the niche enables stem cell function during development and homeostatsis | 000 | 1 | NIH | 2/6/2026 | $395,698 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R37AI097312 | Survival of Neisseria gonorrhoeae after primary human neutrophil challenge | 002 | 12 | NIH | 1/16/2026 | $0 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DA052893 | An investigation of low-intensity focused ultrasound for addiction | 000 | 5 | NIH | 1/30/2026 | $509,673 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | F31HD121344 | Effects of early-life infection and immune signaling on neural development | 000 | 1 | NIH | 1/30/2026 | $41,273 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01GM144668 | The role of microtubule dynamics in midzone driven chromosome segregation in anaphase | 001 | 5 | NIH | 1/28/2026 | $25,227 |
|
